home / stock / aura / aura quote
Last: | $7.49 |
---|---|
Change Percent: | -0.13% |
Open: | $7.71 |
Close: | $7.49 |
High: | $7.715 |
Low: | $7.45 |
Volume: | 83,684 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.49 | $7.71 | $7.49 | $7.715 | $7.45 | 83,684 | 05-07-2024 |
$7.7 | $7.97 | $7.7 | $8.07 | $7.63 | 100,703 | 05-06-2024 |
$7.89 | $8.01 | $7.89 | $8.11 | $7.86 | 100,857 | 05-03-2024 |
$7.77 | $7.76 | $7.77 | $7.77 | $7.46 | 127,570 | 05-02-2024 |
$7.65 | $7.47 | $7.65 | $7.835 | $7.46 | 74,006 | 05-01-2024 |
$7.4 | $7.44 | $7.4 | $7.5 | $7.34 | 78,022 | 04-30-2024 |
$7.5 | $7.31 | $7.5 | $7.93 | $7.31 | 121,714 | 04-29-2024 |
$7.22 | $7.13 | $7.22 | $7.28 | $6.96 | 116,066 | 04-26-2024 |
$7.08 | $7.03 | $7.08 | $7.23 | $6.87 | 117,387 | 04-25-2024 |
$7.1 | $7.18 | $7.1 | $7.345 | $7.095 | 87,949 | 04-24-2024 |
$7.22 | $7.15 | $7.22 | $7.4 | $7.06 | 108,191 | 04-23-2024 |
$7.09 | $7.24 | $7.09 | $7.25 | $7.04 | 107,613 | 04-22-2024 |
$7.19 | $7.03 | $7.19 | $7.19 | $7.03 | 162,912 | 04-19-2024 |
$7.06 | $7.03 | $7.06 | $7.19 | $6.95 | 144,955 | 04-18-2024 |
$7.03 | $7.34 | $7.03 | $7.34 | $6.95 | 140,802 | 04-17-2024 |
$7.26 | $7.26 | $7.26 | $7.405 | $7.2 | 122,955 | 04-16-2024 |
$7.55 | $7.57 | $7.55 | $7.57 | $7.37 | 72,863 | 04-15-2024 |
$7.54 | $7.62 | $7.54 | $7.71 | $7.38 | 95,104 | 04-12-2024 |
$7.7 | $7.7 | $7.7 | $7.82 | $7.55 | 64,922 | 04-11-2024 |
$7.62 | $7.51 | $7.62 | $7.785 | $7.3 | 164,836 | 04-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aura Biosciences Inc. Company Name:
AURA Stock Symbol:
NASDAQ Market:
Although U.S. stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidenc...
Aura Biosciences Inc (NASDAQ: AURA) shares are trading lower by 34.7% to $7.18 Tuesday afternoon after the company announced pricing of its pu...
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2...